11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
暂无分享,去创建一个
Young Chul Youn | Jun Soo Byun | Kwang-Yeol Park | Jae-Won Jang | S. An | Su-Hyun Han | J. Byun | Y. Youn | Kwang-Yeol Park | J. Seok | SangYun Kim | In Kook Chun | Jae-Won Jang | Su-Hyun Han | HyeRyoun Kim | Ju-Won Seok | Seong Soo A An | I. Chun | HyeRyoun Kim | Sangyun Kim
[1] Majaz Moonis,et al. Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees , 2007, The Journal of Neuroscience.
[2] B. Dubois,et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. , 1999, American journal of human genetics.
[3] G. Leuba,et al. Early-onset familial Alzheimer disease with coexisting beta-amyloid and prion pathology. , 2000, JAMA.
[4] Jessica A. Grahn,et al. The cognitive functions of the caudate nucleus , 2008, Progress in Neurobiology.
[5] E. Bigio,et al. Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis , 2002, Neuropathology and applied neurobiology.
[6] J. Cummings,et al. Early-Onset Alzheimer’s Disease Is Associated With Greater Pathologic Burden , 2007, Journal of geriatric psychiatry and neurology.
[7] Nick C Fox,et al. Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. , 2011, Brain : a journal of neurology.
[8] Jason D. Warren,et al. Disintegrating Brain Networks: from Syndromes to Molecular Nexopathies , 2012, Neuron.
[9] M. Weiner,et al. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. , 2010, Brain : a journal of neurology.
[10] G. Schellenberg,et al. Familial prion disease with alzheimer disease‐like tau pathology and clinical phenotype , 2011, Annals of neurology.
[11] M. Witter,et al. Contributions of Thalamic Nuclei to Declarative Memory Functioning , 2003, Cortex.
[12] M. Viitanen,et al. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease , 2006, Neurology.
[13] Young Chul Youn,et al. Voxel-based morphometric study of brain volume changes in patients with Alzheimer’s disease assessed according to the Clinical Dementia Rating score , 2011, Journal of Clinical Neuroscience.
[14] S. Aalto,et al. Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication. , 2008, Archives of neurology.
[15] H. Chui,et al. Clinical subtypes of dementia of the Alzheimer type , 1985, Neurology.
[16] Masanori Nakagawa,et al. High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. , 2009, Archives of neurology.
[17] Sue J. Kang,et al. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. , 2005, Brain : a journal of neurology.
[18] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[19] T. Khan,et al. Clinical Diagnosis of Alzheimer’s Disease , 2017 .
[20] Nick C Fox,et al. Amyloid, hypometabolism, and cognition in Alzheimer disease , 2007, Neurology.
[21] H. Braak,et al. Alzheimer's disease affects limbic nuclei of the thalamus , 2004, Acta Neuropathologica.
[22] G. Frisoni,et al. Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[23] P. Strick,et al. Basal Ganglia Output and Cognition: Evidence from Anatomical, Behavioral, and Clinical Studies , 2000, Brain and Cognition.
[24] Sang Won Seo,et al. Amyloid deposition in early onset versus late onset Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.